← Back to Search

Procedure

Fetoscopic Surgery for Spina Bifida

N/A
Recruiting
Led By Ruben Quintero, MD
Research Sponsored by USFetus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Maternal age ≥18 years
Myelomeningocele (including myeloschisis) at level T1 through S1 with hindbrain herniation confirmed by MRI and ultrasonography
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of surgery until delivery, up to 21 weeks
Awards & highlights

Study Summary

This trial will test two different ways to operate on fetuses with myelomeningocele (a birth defect where the spinal cord doesn't form properly). One approach goes through the mother's skin (percutaneous), and the other goes through the mother's belly (laparotomy/uterine exteriorization).

Who is the study for?
This trial is for pregnant women over 18 with a fetus diagnosed with myelomeningocele, between 19-27 weeks' gestation. They must be able to stay near Wellington or Pasadena for the pregnancy and delivery, and return for follow-ups. Exclusions include multiple pregnancies, certain health conditions like HIV/Hepatitis-B, obesity (BMI of 35+), nickel allergy, pregestational diabetes, uterine anomalies, previous early deliveries.Check my eligibility
What is being tested?
The study tests a fetoscopic surgical technique versus traditional surgery to correct fetal myelomeningocele before birth. The percutaneous approach is used if the placenta is at the back; otherwise laparotomy/uterine exteriorization can be done regardless of placental location.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include typical risks associated with surgeries such as infection risk at the incision site, bleeding complications during or after surgery, possible adverse reactions to anesthesia or materials used in surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have a spinal defect from T1 to S1 with brain tissue protrusion, confirmed by MRI and ultrasound.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of surgery until delivery, up to 21 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of surgery until delivery, up to 21 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of successful in-utero fetoscopic myelomeningocele closures using either laparotomy or percutaneous techniques

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fetoscopic repairExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Wellington HospitalOTHER_GOV
8 Previous Clinical Trials
1,347 Total Patients Enrolled
University of Southern CaliforniaOTHER
906 Previous Clinical Trials
1,596,276 Total Patients Enrolled
1 Trials studying Spina Bifida
110 Patients Enrolled for Spina Bifida
USFetusLead Sponsor
1 Previous Clinical Trials
110 Total Patients Enrolled
1 Trials studying Spina Bifida
110 Patients Enrolled for Spina Bifida

Media Library

Fetoscopy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03856034 — N/A
Spina Bifida Research Study Groups: Fetoscopic repair
Spina Bifida Clinical Trial 2023: Fetoscopy Highlights & Side Effects. Trial Name: NCT03856034 — N/A
Fetoscopy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03856034 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have joined this research project thus far?

"Affirmative. The clinical trial is still hoping to enrol participants, as indicated on the clinicaltrials.gov website – which was first published in November 2018 and updated last year. A total of 12 patients need to be enrolled from two separate sites."

Answered by AI

Are there any open vacancies in this clinical experiment?

"This trial is still open to participants, with the original posting date on November 2nd 2018 and last update on November 11th 2019. This information can be found on clinicaltrials.gov."

Answered by AI
~2 spots leftby Apr 2025